Ajay K. Singh, MB, FRCP is Senior Associate Dean for Global and Continuing Education at Harvard Medical School and Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program; Clinical Chief, Renal Division, Brigham and Women’s Hospital; and Associate Professor of Medicine, Harvard Medical School. He is a co-author of The Brigham Intensive Review of Internal Medicine, 3rd Edition.
Dr. Singh completed his medical training in England at University College London School of Medicine, after which he moved to Boston for his clinical and research renal fellowship at Tufts-New England Medical Center. Dr. Singh has been Executive Director for the Dubai Harvard Foundation of Medical Research since 2008 and is listed as one of America’s Top Doctors by Castle Connolly.
Dr. Singh’s interests are in clinical research, with a particular focus on the anemia of chronic kidney disease. He led groundbreaking studies in anemia of kidney disease, including the CHOIR study, which was published in the New England Journal of Medicine, and well as being a member of the steering committees for the TREAT and DRIVE studies. More recently, he has taken on the role of leading the ASCEND Clinical development program – a phase 3 program for the development of a novel propel hydroxyls inhibitor Daprodustat.
Dr. Singh is currently Chair of the Editorial Board for Nephrology Times and formerly Editor-in-Chief of Scientific American Medicine. He leads the office of Postgraduate Medical Education at the Brigham and Women’s Hospital and in this capacity leads several HMS CME courses. He is the author of over 150 original contributions and review articles, as well as author/editor of 11 books in in internal medicine and nephrology. Dr. Singh is a Fellow of the Royal College of Physicians in London, and has an MBA from Boston University.